Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain

Updated 06/21/2024

Status Completed

Clinical Trial Summary

A Randomized, Double-blind, Active-Controlled, Multi-center, Phase 3 Trial to Compare the Safety and Efficacy between YHD1119 and Pregabalin in Patients with Peripheral Neuropathic Pain

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02985216
Study type	Interventional
Source	Yuhan Corporation
Contact
Status	Completed
Phase	Phase 3
Start date	February 7, 2017
Completion date	May 2, 2018

See also
	Status	Clinical Trial	Phase
	Completed	`NCT03733886` - Burst Spinal Cord Stimulation for Neuropathic Pain.	N/A
	Completed	`NCT04494815` - A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419	Phase 1/Phase 2
	Recruiting	`NCT04431778` - Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain	Phase 2
	Completed	`NCT03191136` - Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers	Phase 1
	Completed	`NCT02100046` - Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.	Phase 2
	Completed	`NCT05416931` - ACD440 Gel in Peripheral Neuropathic Pain	Phase 2
	Completed	`NCT06234917` - Increasing Sensori-Motor Rhythm Activity by EEG-Neurofeedback to Reduce the Impact of Pain on Daily Functioning	N/A
	Completed	`NCT03009500` - Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain	Phase 3
	Completed	`NCT01524796` - NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark
	Recruiting	`NCT04171453` - Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets
	Completed	`NCT01737294` - Observation of the Use of QUTENZA™ in Standard Clinical Practice	N/A
	Active, not recruiting	`NCT05890053` - To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia	Phase 3
	Completed	`NCT05219812` - A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain	Phase 2
	Terminated	`NCT01293851` - Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
	Completed	`NCT02209896` - BlueWind Reprieve System for the Treatment of PNP	N/A
	Completed	`NCT01240148` - Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers	Phase 1
	Recruiting	`NCT05817591` - Response Profiles to High-concentration Capsaicin Desensitization in Patients With Peripheral Neuropathic Pain With or Without Allodynia: a Regional Multicenter Prospective Cohort